Atika Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-167,000	Closed	-$3.8M	–	110
2024 Q3	$3.8M	Buy	+167,000	New	+$3.8M	0.39%	64
2024 Q1	–	Sell	-39,000	Closed	-$849K	–	108
2023 Q4	$849K	Buy	+39,000	New	+$849K	0.11%	67